PPA2 Human

Pyrophosphatase-2 Human Recombinant
Cat. No.
BT30897
Source
Escherichia Coli.
Synonyms
PPA2, Pyrophosphatase-2, Inorganic pyrophosphatase 2, mitochondrial, PPase 2, Pyrophosphatase SID6-306, Pyrophosphate phospho-hydrolase 2, HSPC124, Pyrophosphatase (inorganic) 2, SID6-306, Inorganic pyrophosphatase 2, mitochondrial isoform 1.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

PPA2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 325 amino acids (33-334 a.a) and having a molecular mass of 37.1kDa.
PPA2 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
PPA2 exhibits significant similarity to members of the inorganic pyrophosphatase (PPase) family. Primarily located within the mitochondria, PPA2 possesses the specific sequence crucial for PPase catalytic function. PPases play a vital role in cellular phosphate metabolism by facilitating the hydrolysis of pyrophosphate to inorganic phosphate.
Description
Recombinant human PPA2 protein, expressed in E. coli, is a single, non-glycosylated polypeptide chain. It comprises 325 amino acids (33-334 a.a), resulting in a molecular weight of 37.1kDa. The protein includes a 23 amino acid His-tag fused at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
The product is a sterile, colorless solution that has undergone filtration.
Formulation
The PPA2 protein solution has a concentration of 1mg/ml and is supplied in a buffer consisting of 20mM Tris-HCl (pH 8.0), 0.15M NaCl, 10% glycerol, and 1mM DTT.
Stability
For short-term storage (2-4 weeks), the product should be kept at 4°C. For extended storage, it is recommended to freeze the product at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is advisable for long-term storage. Repeated freeze-thaw cycles should be avoided.
Purity
SDS-PAGE analysis indicates a purity exceeding 95.0%.
Synonyms
PPA2, Pyrophosphatase-2, Inorganic pyrophosphatase 2, mitochondrial, PPase 2, Pyrophosphatase SID6-306, Pyrophosphate phospho-hydrolase 2, HSPC124, Pyrophosphatase (inorganic) 2, SID6-306, Inorganic pyrophosphatase 2, mitochondrial isoform 1.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSALYHTEE RGQPCSQNYR LFFKNVTGHY ISPFHDIPLK VNSKEENGIP MKKARNDEYE NLFNMIVEIP RWTNAKMEIA TKEPMNPIKQ YVKDGKLRYV ANIFPYKGYI WNYGTLPQTW EDPHEKDKST NCFGDNDPID VCEIGSKILS CGEVIHVKIL GILALIDEGE TDWKLIAINA NDPEASKFHD IDDVKKFKPG YLEATLNWFR LYKVPDGKPE NQFAFNGEFK NKAFALEVIK STHQCWKALL MKKCNGGAIN CTNVQISDSP FRCTQEEARS LVESVSSSPN KESNEEEQVW HFLGK.

Product Science Overview

Introduction

Pyrophosphatase-2 (PPA2) is an enzyme that plays a crucial role in cellular metabolism by hydrolyzing inorganic pyrophosphate (PPi) into two orthophosphate molecules. This reaction is essential for various biochemical processes, including nucleotide synthesis, protein synthesis, and energy metabolism. The human recombinant form of PPA2 is produced using recombinant DNA technology, which allows for the expression of the enzyme in a host organism, typically bacteria or yeast.

Structure and Function

PPA2 is a mitochondrial enzyme that is encoded by the PPA2 gene. The enzyme is highly conserved across different species, indicating its fundamental role in cellular processes. The primary function of PPA2 is to maintain the balance of inorganic pyrophosphate within the cell. By hydrolyzing PPi, PPA2 prevents the accumulation of this molecule, which can be inhibitory to various biosynthetic reactions.

The enzyme’s activity is crucial for the proper functioning of metabolic pathways, including the synthesis of nucleotides and proteins. In the absence of PPA2 activity, cells can experience an imbalance in PPi levels, leading to metabolic dysregulation and potential cellular damage.

Clinical Significance

Mutations in the PPA2 gene have been associated with severe clinical outcomes, including sudden cardiac death. Research has shown that biallelic hypomorphic variants in PPA2 can lead to mitochondrial dysfunction, resulting in conditions such as sudden cardiac failure and progressive neurological disease . These findings highlight the importance of PPA2 in maintaining cellular homeostasis and its potential role in disease pathogenesis.

Recombinant Production

The production of human recombinant PPA2 involves the insertion of the human PPA2 gene into a suitable expression vector, which is then introduced into a host organism. The host organism, often a strain of Escherichia coli or Saccharomyces cerevisiae, expresses the PPA2 enzyme, which can then be purified for research or therapeutic use.

Recombinant PPA2 is used in various biochemical assays to study its activity and regulation. These assays help in understanding the enzyme’s role in cellular metabolism and its potential as a therapeutic target for diseases associated with PPA2 dysfunction.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.